A LEEP (Loop Electrosurgical Excision Procedure) is often followed by a biopsy of the excised tissue. This analysis provides a definitive diagnosis of the cervical tissue’s condition. The laboratory report typically details the presence or absence of abnormal cells, specifying the type and severity of any dysplasia or cancerous changes. For example, the report might indicate the presence of CIN (Cervical Intraepithelial Neoplasia) and classify it as CIN 1, 2, or 3, indicating mild to severe dysplasia.
Post-LEEP biopsy assessment is crucial for determining the completeness of the excision and assessing the need for further treatment. This information guides clinical management, helping healthcare providers determine whether additional procedures, like a cone biopsy or hysterectomy, are necessary. The pathological assessment also contributes to long-term patient care by aiding in risk stratification for recurrence and informing the frequency and nature of follow-up surveillance. The development of this diagnostic procedure has significantly improved the early detection and treatment of cervical pre-cancers and cancers, contributing to more positive patient outcomes.
